CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2025	Sep. 28, 2024
Cash flows from operating activities:
Consolidated net income	$ 376,148	$ 293,619
Adjustments to reconcile consolidated net income to net cash (used for) provided by operations:
Depreciation and amortization	103,765	123,356
Amortization of stock-based compensation	20,448	30,187
Equity in earnings of affiliated companies	(1,124)	(1,912)
Deferred income taxes	5,185	(20,287)
Loss on extinguishment of debt	0	1,657
(Gain) loss on investments, net	(109,435)	925
Other	(77)	4,346
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable, net	(2,292,091)	512,394
Inventories	65,225	662,685
Accounts payable	1,871,455	(687,015)
Accrued expenses	(94,367)	189,537
Other assets and liabilities	(81,033)	(305,543)
Net cash (used for) provided by operating activities	(135,901)	803,949
Cash flows from investing activities:
Acquisition of property, plant, and equipment	(73,873)	(70,155)
Proceeds from settlement of net investment hedges	24,858	10,635
Proceeds from sale of investments in equity securities	100,000	0
Other	0	6,494
Net cash provided by (used for) investing activities	50,985	(53,026)
Cash flows from financing activities:
Change in short-term and other borrowings	9,852	(595,069)
Proceeds from long-term bank borrowings, net	338,223	60,158
Redemption of notes	(350,000)	(1,000,000)
Net proceeds from note offering	0	989,564
Proceeds from exercise of stock options	3,427	5,353
Repurchases of common stock	(110,779)	(214,352)
Other	(148)	(1,040)
Net cash used for financing activities	(109,425)	(755,386)
Effect of exchange rate changes on cash	219,146	34,410
Net increase in cash and cash equivalents	24,805	29,947
Cash and cash equivalents at beginning of period	188,807	218,053
Cash and cash equivalents at end of period	$ 213,612	$ 248,000